Time for Innovative Medicines Fund 2.0 in England: Industry and Patients Want Change

 
• By Leela Barham
  
England's Innovative Medicines Fund should be made more commercially attractive to companies, say industry representatives. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pricing Debate